滑盘安装式均质机

在成功用于治疗癌症、肿瘤和其他恶性疾病后，单克隆抗体药物的行业规模稳步增加，吸引着越来越多的制药公司加入这个市场。

GEA has responded to the changing needs of biopharmaceutical manufacturers and developed improved technology solutions to optimize both upstream and, with increasing titers, downstream processing, in terms of time and cost efficiency.

GEA fundamentally understands the processes involved in vaccine production, the capabilities of the technologies employed and the engineering required to ensure that they operate at optimum capacity with the lowest maintenance.

作为胰岛素生产领域的全球技术领导者，GEA 能供应洁净公用工程系统，并且整合所有的主要工艺，包括发酵、收获、层析、超滤、过滤和冷冻干燥。